Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -18.44%4.69B | -21.81%25.04B | -40.30%5.75B | -25.52%32.02B | -15.63%6.42B | -22.88%6.8B | -38.35%9.17B | -17.63%9.63B | 5.01%43B | -17.85%7.61B |
| Cost of revenue | -21.16%1.84B | -16.05%10.83B | -34.85%2.34B | -23.47%12.9B | -1.71%2.95B | -15.60%2.81B | -40.80%3.54B | -20.79%3.59B | 6.32%16.85B | -14.16%3B |
| Gross profit | -16.55%2.84B | -25.68%14.22B | -43.55%3.41B | -26.84%19.13B | -24.71%3.47B | -27.29%3.99B | -36.70%5.63B | -15.62%6.04B | 4.19%26.15B | -20.09%4.6B |
| Operating expense | 14.36%3.67B | -27.40%13.58B | -26.41%3.21B | -6.51%18.71B | 17.09%4.9B | -14.62%4.39B | -4.84%5.06B | -18.77%4.36B | 9.87%20.01B | -14.47%4.18B |
| Staff costs | -3.06%444M | 6.54%1.74B | 6.49%458M | 10.54%1.64B | 11.95%510.09M | 3.51%292.91M | 17.82%403.93M | 7.67%430.07M | 6.14%1.48B | 2.35%455.65M |
| Selling and administrative expenses | 14.49%1.49B | -27.29%7.85B | -39.81%1.3B | -19.28%10.8B | 0.75%3.66B | -29.70%2.17B | -14.83%2.82B | -35.80%2.15B | 11.76%13.38B | -17.92%3.63B |
| -Selling and marketing expense | 14.49%1.49B | -34.47%5.86B | -39.81%1.3B | -24.68%8.94B | -15.16%1.81B | -29.70%2.17B | -14.83%2.82B | -35.80%2.15B | 12.19%11.87B | -29.96%2.13B |
| -General and administrative expense | ---- | 7.33%1.99B | ---- | 23.25%1.86B | ---- | ---- | ---- | ---- | 8.44%1.51B | ---- |
| Research and development costs | -16.11%177M | -9.12%847M | -5.65%211M | 10.27%932M | -46.40%157.63M | 3.49%260.37M | 71.07%290.36M | 72.31%223.64M | 63.89%845.18M | 188.15%294.07M |
| Depreciation and amortization | 45.45%80M | 34.58%288M | 23.66%55M | 6.15%214M | 51.79%66.92M | 24.75%54.08M | -15.14%48.52M | -21.94%44.48M | 3.65%201.6M | -11.17%44.08M |
| -Depreciation | -18.18%45M | -9.35%194M | 23.66%55M | 6.15%214M | 51.79%66.92M | 24.75%54.08M | -15.14%48.52M | -21.94%44.48M | 3.65%201.6M | -11.17%44.08M |
| -Amortization | --35M | --94M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | 24.87%1.49B | -44.40%2.85B | -21.20%1.19B | 24.88%5.13B | 301.48%498.75M | 8.95%1.62B | 4.19%1.5B | 5.71%1.51B | -0.78%4.1B | -80.82%-247.54M |
| Operating profit | -520.30%-828M | 51.07%633M | -88.23%197M | -93.17%419M | -437.95%-1.43B | -216.24%-400.76M | -83.96%574.63M | -6.15%1.67B | -10.84%6.13B | -51.57%422.92M |
| Net non-operating interest income (expenses) | 266.67%5M | 110.00%2M | 44.53%-3M | 10.45%-20M | -278.50%-9.56M | 54.56%-2.44M | 71.30%-2.59M | 0.00%-5.41M | -83.01%-22.33M | -9.87%-2.53M |
| Non-operating interest income | --6M | 1,200.00%13M | --0 | -32.30%1M | -75.65%151K | 458.55%849K | -116.16%-91K | -35.92%91K | 37.78%1.48M | 50.85%620K |
| Non-operating interest expense | -66.67%1M | -47.62%11M | -45.44%3M | -11.80%21M | 208.71%9.71M | -40.42%3.29M | -73.93%2.5M | -0.92%5.5M | 79.36%23.81M | 16.09%3.15M |
| Net investment income | 202.00%51M | -112.04%-140M | -112.68%-50M | 274.09%1.16B | 99.47%444.68M | 92.03%-130.68M | -63.81%454.63M | -16.38%394.37M | -75.99%310.89M | -76.81%222.93M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 59.29%-46M | 67.47%-176M | 54.08%-113M | -18.29%-541M | 64.41%-64.46M | -1,618.25%-25.54M | -55.45%-204.93M | -68.50%-246.07M | -340.21%-457.33M | -389.34%-181.15M |
| Special income (charges) | -100.00%-6M | 2,896.77%867M | 81.56%-3M | 61.49%-31M | 16.79%-5.6M | -289.81%-3.4M | 92.14%-5.73M | -16.27M | -81.79%-80.5M | 78.30%-6.73M |
| Less:Other special charges | 100.00%6M | -2,964.52%-888M | -81.56%3M | -61.49%31M | -16.79%5.6M | 289.81%3.4M | --5.73M | --16.27M | 81.79%80.5M | -78.30%6.73M |
| Less:Write off | ---- | --21M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 158.33%7M | 20.00%-4M | -1,578.32%-12M | 89.70%-5M | 32.69%3.22M | 99.55%-215K | -170.32%-7.29M | -266.67%-715K | -1,299.01%-48.54M | 229.66%2.42M |
| Income before tax | -6,908.33%-817M | 20.25%1.18B | -99.33%12M | -83.24%978M | -333.24%-1.07B | 58.59%-558.04M | -82.61%803.73M | -14.44%1.8B | -27.21%5.84B | -74.06%457.87M |
| Income tax | -39.18%59M | -19.14%469M | -85.24%97M | -69.85%580M | -357.21%-306.46M | 71.15%-109.54M | -76.84%338.6M | -9.04%657.4M | -20.90%1.92B | -73.09%119.15M |
| Net income | -944.05%-877M | 77.39%706M | -107.35%-84M | -89.83%398M | -324.81%-761.5M | 53.67%-448.5M | -85.29%465.13M | -17.26%1.14B | -29.96%3.91B | -74.38%338.73M |
| Net income continuous operations | -930.59%-876M | 77.64%707M | -107.44%-85M | -89.83%398M | -324.81%-761.5M | 53.67%-448.5M | -85.29%465.13M | -17.26%1.14B | -29.96%3.91B | -74.38%338.73M |
| Noncontrolling interests | 0 | 0 | 0 | |||||||
| Net income attributable to the company | -944.05%-877M | 77.39%706M | -107.35%-84M | -89.83%398M | -324.81%-761.5M | 53.67%-448.5M | -85.29%465.13M | -17.26%1.14B | -29.96%3.91B | -74.38%338.73M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -944.05%-877M | 77.39%706M | -107.35%-84M | -89.83%398M | -324.81%-761.5M | 53.67%-448.5M | -85.29%465.13M | -17.26%1.14B | -29.96%3.91B | -74.38%338.73M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -935.06%-15.94 | 77.49%12.85 | -107.41%-1.54 | -89.82%7.24 | -324.51%-13.83 | 53.58%-8.17 | -85.26%8.47 | -17.28%20.77 | -29.96%71.12 | -74.37%6.16 |
| Diluted earnings per share | -935.06%-15.94 | 77.49%12.85 | -107.41%-1.54 | -89.82%7.24 | -324.81%-13.8402 | 53.58%-8.17 | -85.29%8.4536 | -17.28%20.77 | -29.96%71.12 | -74.38%6.1563 |
| Dividend per share | 0 | 0.00%9 | 0 | 5.88%9 | 11.76%4.75 | 0 | 0.00%4.25 | 0 | 112.50%8.5 | 112.50%4.25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |